allogreffe de moelle osseuse

CONT: Évolution du tissu osseux après allogreffe de moelle osseuse chez l'adolescent drépanocytaire

CONT: Allogenic B.M.T. has been investigated as a curative treatment of anemia in S.C.D. [sickle cell disease]. Furthermore, correction of functional asplenia has been observed after B.M.T.; it remains to be determined if such a treatment may reserve other organ damage and particularly bone abnormalities and osteonecrosis frequently associated with S.C. hemoglobinopathies.
OBS: Bone Marrow transplantation (B.M.T.) and correction of bone abnormalities associated with sickle cell disease (S.C.D.)